« Previous Next » PAIN
Volume 152, Issue 1 , Pages 14-27 , January 2011

NeuPSIG guidelines on neuropathic pain assessment

Maija Haanpää
- Rehabilitation ORTON, Helsinki, Finland
- Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland
- Corresponding author at: Department of Neurosurgery, Helsinki University Central Hospital, P.O. Box 266, 00029 HUS, Helsinki, Finland. Tel.: +358 50 5837722; fax: +358 9 47187560.
Nadine Attal
- INSERM U-987, Centre d’Evaluation et de Traitement de la Douleur, Hoˆpital Ambroise Pare´, APHP, Boulogne-Billancourt, France
- Universite´ Versailles Saint-Quentin, France
Miroslav Backonja
- Department of Neurology, University of Wisconsin, Madison, WI, USA
Ralf Baron
- Division of Neurological Pain Research and Therapy, Department of Neurology, Universitatsklinikum Schleswig-Holstein, Kiel, Germany
Michael Bennett
- Institute of Health Research, Lancaster University, Lancaster University, Lancaster, UK
Didier Bouhassira
- INSERM U-987, Centre d’Evaluation et de Traitement de la Douleur, Hoˆpital Ambroise Pare´, APHP, Boulogne-Billancourt, France
- Universite´ Versailles Saint-Quentin, France
Giorgio Cruccu
- Department of Neurology, La Sapienza University, Rome, Italy
Per Hansson
- Pain Center, Department of Anesthesiology and Intensive Care, Clinical Pain Research, Karolinska University Hospital/Institutet, Stockholm, Sweden
Jennifer A. Haythornthwaite
- Johns Hopkins University, Baltimore, MD, USA
Gian Domenico Iannetti
- Department of Neuroscience, Physiology and Pharmacology, University College London, London, UK
Troels S. Jensen
- Danish Pain Research Center and Department of Neurology, Aarhus University Hospital, Aarhus, Denmark
Timo Kauppila
- Korso-Koivukylä Health Centre, Vantaa, Finland
- Network of Academic Health Centres, Departments of General Practice and Primary Healthcare, Institute of Clinical Medicine and Department of National Public Health, University of Helsinki, Helsinki, Finland
Turo J. Nurmikko
- Pain Research Institute, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK
Andew S.C. Rice
- Department of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London, London, UK
Michael Rowbotham
- Department of Neurology, QCSF Pain Clinic Research Center, University of California, San Francisco, CA, USA
Jordi Serra
- Department of Neurology, MC Mutual & Neuroscience Technologies, Barcelona Science Park, Barcelona, Spain
Claudia Sommer
- Department of Neurology, University of Würzburg, Germany
Blair H. Smith
- Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK
Rolf-Detlef Treede
- Center for Biomedicine and Medical Technology Mannheim, Heidelberg University, Mannheim, Germany

Received 29 August 2009 ,Revised 2 July 2010 ,Accepted 29 July 2010.

Title	About	Type	File Size
Supplementary Table 1	Information on case identification and ascertainment from the epidemiological papers.		0 MB
Supplementary Table 2	Validation studies of the screening tools of neuropathic pain.		0 MB
Supplementary Table 3	Studies on quantitative somatosensory testing.		0 MB
Supplementary Table 4	Studies on treatment of neuropathic pain.		0 MB
Supplementary Table 5	Psychological factors in neuropathic pain.		0 MB
Supplementary Table 6	Studies on neuropathic pain with assessment of disability.		0 MB
Supplementary Table 7	Studies on neuropathic pain with assessment of quality of life.		0 MB
Supplementary Table 8	Change of quality of life in randomized controlled trials on neuropathic pain.		0 MB
Supplementary Table 9	Reflexes as a diagnostic tool.		0 MB
Supplementary Table 10	Evoked potentials as a diagnostic tool.		0 MB
Supplementary Table 11	Microneurography studies.		0 MB
Supplementary Table 12	PET/fMRI as a diagnostic tool.		0 MB
Supplementary Table 13	PET/fMRI in assessing treatment.		0 MB
Supplementary Table 14	Studies on skin biopsy in neuropathies and neuropathic pain.		0 MB
Supplementary Table 15	Studies on autonomic nervous system function in neuropathic pain.		0 MB
Supplementary Appendix 1	Search strategies.		0 MB
Supplementary Appendix 2	Inclusion and exclusion criteria for epidemiological papers.		0 MB
Supplementary Appendix 3	Measures of disability.		0 MB
Supplementary data 19	References.		0 MB